Summary
Updated Aug 31, 2026
Thomas McGauley is Interim CFO of TENAX THERAPEUTICS, INC. (TENX). 2 SEC Form 4 filings on record going back to 2025, most recently on 3 February 2026. Most recent open-market trade: bought $36K of TENX on 19 November 2025. Lifetime open-market purchases: $58K. Historical track record: 5/5 stars across 3 tracked purchases.
Recent Transactions
3Every recent SEC Form 4 transaction Thomas McGauley has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +22.45% |
| Avg 30-day return | +60.41% |
| Avg 90-day return | +69.80% |
| Best 30-day return | +60.41% |
Trading Pattern
InsiderAlpha's records for Thomas McGauley go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. The typical open-market purchase is $19K (3 buys totaling $58K). The largest single buy on record is $36K of TENX in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas McGauley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $1.81M of TENX open-market activity in the last 12 months
- Stuart Rich - $46K of TENX open-market activity in the last 12 months
- Christopher Thomas Giordano - $20K of TENX open-market activity in the last 12 months
- June Sherie Almenoff - $15K of TENX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Thomas McGauley?
Thomas McGauley is a corporate insider, tracked as Interim CFO of TENAX THERAPEUTICS, INC. (TENX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Thomas McGauley last file a Form 4?
The most recent primary Form 4 on record is dated 3 February 2026, one of 2 filings going back to 2025.
Has Thomas McGauley been buying or selling stock?
Recorded transactions: 3 open-market purchases ($58K) and 0 open-market sales across all tracked filings.
How accurate is Thomas McGauley's historical track record?
Across 3 tracked purchases, Thomas McGauley averaged +60.4% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Thomas McGauley's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Thomas McGauley and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial